These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14709961)

  • 21. High-dose quetiapine and photopsia.
    Hazra M; Culo S; Mamo D
    J Clin Psychopharmacol; 2006 Oct; 26(5):546-7. PubMed ID: 16974209
    [No Abstract]   [Full Text] [Related]  

  • 22. Postictal psychosis successfully treated with quetiapine: a case report.
    Marino J; Augsten A; Henry J
    Ann Pharmacother; 2009 Sep; 43(9):1544. PubMed ID: 19690225
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quetiapine in the treatment of postoperative delirium. A report of three cases.
    Khouzam HR
    Compr Ther; 2008; 34(3-4):207-17. PubMed ID: 19137765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study.
    Boidi G; Ferro M
    Hum Psychopharmacol; 2007 Jul; 22(5):299-306. PubMed ID: 17487936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interaction can lead to undetectable serum concentrations of quetiapine in the presence of carbamazepine.
    Nickl-Jockschat T; Paulzen M; Schneider F; Grözinger M
    Clin Neuropharmacol; 2009; 32(1):55. PubMed ID: 19471186
    [No Abstract]   [Full Text] [Related]  

  • 28. The efficacy and safety of quetiapine for treatment of geriatric psychosis.
    Yang CH; Tsai SJ; Hwang JP
    J Psychopharmacol; 2005 Nov; 19(6):661-6. PubMed ID: 16272189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quetiapine-induced peripheral edema.
    Roy K; Astreika V; Dunn JE; Sappati Biyyani RS
    Gen Hosp Psychiatry; 2009; 31(2):194-5. PubMed ID: 19269545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
    Jagadheesan K; Muirhead D
    Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830
    [No Abstract]   [Full Text] [Related]  

  • 31. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.
    Philip NS; Mello K; Carpenter LL; Tyrka AR; Price LH
    Ann Clin Psychiatry; 2008; 20(1):15-20. PubMed ID: 18297582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Administration of once-daily extended release quetiapine in schizophrenic disorders].
    Bartkó G
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):189-95. PubMed ID: 18510263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is antipsychotic drug therapy predictable?].
    Leinonen E; Anttila S; Kampman O; Illi A
    Duodecim; 2005; 121(1):45-52. PubMed ID: 15712835
    [No Abstract]   [Full Text] [Related]  

  • 34. Depot antipsychotic drugs and prevention of psychotic relapse.
    Barnes TR
    Clin Neuropharmacol; 1991; 14 Suppl 2():S1-6. PubMed ID: 1684307
    [No Abstract]   [Full Text] [Related]  

  • 35. Priapism and quetiapine: a case report.
    Harrison G; Dilley JW; Loeb L; Nelson K
    Psychopharmacol Bull; 2006; 39(1):117-9. PubMed ID: 17065976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study.
    Goldberg JF; Kelley ME; Rosenquist KJ; Hsu DJ; Filkowski MM; Nassir Ghaemi S
    J Affect Disord; 2008 Jan; 105(1-3):305-10. PubMed ID: 17550787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic drug monitoring of quetiapine in adolescents with psychotic disorders.
    Gerlach M; Hünnerkopf R; Rothenhöfer S; Libal G; Burger R; Clement HW; Fegert JM; Wewetzer Ch; Mehler-Wex C
    Pharmacopsychiatry; 2007 Mar; 40(2):72-6. PubMed ID: 17447177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Schizoaffective disorder].
    Ikegami K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):102-6. PubMed ID: 12876940
    [No Abstract]   [Full Text] [Related]  

  • 40. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
    J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.